• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MannKind Corp

+ Add to Watchlist

MNKD:US

6.1500 USD 0.1100 1.76%

As of 12:37:00 ET on 11/28/2014.

Snapshot for MannKind Corp (MNKD)

Open: 6.2400 Day's Range: 6.1400 - 6.2900 Volume: 1,364,437
Previous Close: 6.2600 52wk Range: 3.8000 - 11.4800 1-Yr Rtn: +23.25%

Stock Chart for MNKD

No chart data available.
  • MNKD:US 6.1400
  • 1D
  • 1M
  • 1Y
6.2600
Interactive MNKD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNKD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5800
Est. EPS (USD) (12/2014) -0.5260
Est. PEG Ratio -
Market Cap (M USD) 2,539.68
Shares Outstanding (M) 405.70
30 Day Average Volume 4,619,411
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNKD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNKD

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

Alfred E MannChairman/CEOHakan S EdstromPresident/COO
Matthew J Pfeffer "Matt"VP/CFO/Investor RelationsDavid B ThomsonVP/Secy/General Counsel
More Company Profile & Key Executives for MNKD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil